All Alexion Pharmaceuticals articles

  • Alexion

    Alexion Pharmaceuticals to pay $21M to resolve FCPA case


    Alexion Pharmaceuticals will pay $21 million to resolve SEC charges that it violated the books and records and internal accounting controls provisions of the FCPA concerning bribes made by subsidiaries to foreign government officials.

  • Money

    Alexion nears $25M settlement with SEC in FCPA probe


    Alexion Pharmaceuticals said in a regulatory filing that it is nearing a $25 million settlement with the Securities and Exchange Commission concerning an investigation into the company’s compliance with the Foreign Corrupt Practices Act spanning various countries.